SCOPUS 정보 검색 플랫폼

Volumn 37, Issue 1, 2002, Pages 124-130

Early hepatitis C viral kinetics correlate with long-term outcome in patients receiving high dose induction followed by combination interferon and ribavirin therapy

(7) Rosen, Hugo R a,b Ribeiro, Ruy R c Weinberger, Leor c Wolf, Stephanie a Chung, Minjun d Gretch, David R d Perelson, Alan S c

a PORTLAND VA MEDICAL CENTER (United States)

b OREGON HEALTH AND SCIENCE UNIVERSITY (United States)

c LOS ALAMOS NATIONAL LABORATORY (United States)

d UNIVERSITY OF WASHINGTON (United States)

Author keywords

Combination interferon and ribavirin therapy; Early hepatitis C viral kinetics; High dose induction; Long term outcome

Indexed keywords

ALPHA2B INTERFERON; RIBAVIRIN; ANTIVIRUS AGENT; INTERFERON; VIRUS RNA;

ADULT; ARTICLE; CELL LOSS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG FORMULATION; DRUG RESPONSE; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KINETICS; LONG TERM CARE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE; TREATMENT OUTCOME; VIRUS LOAD; BLOOD; DRUG COMBINATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; PROSPECTIVE STUDY;

ADULT; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMAN; INTERFERONS; KINETICS; MALE; PROSPECTIVE STUDIES; RIBAVIRIN; RNA, VIRAL; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TREATMENT OUTCOME; HUMANS;

EID: 0035991450 PISSN: 01688278 EISSN: None Source Type: Journal
DOI: 10.1016/S0168-8278(02)00114-9 Document Type: Article

Times cited : (37)

References (24)

1
- 0009653784

2
- 0033831446
- Viral hepatitis in the liver transplant recipient
- (2000) Infect Dis Clin North Am , vol.3 , pp. 761-784
- Rosen, H.R.¹ Martin, P.²

3
- 0032548032
- Combination therapy for hepatitis C infection
- (1998) N Engl J Med , vol.339 , pp. 1549-1550
- Liang, T.J.¹

4
- 0032547938
- Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
- (1998) N Engl J Med , vol.339 , pp. 1485-1492
- McHutchison, J.G.¹ Gordon, S.C.² Schiff, E.R.³ Shiffman, M.L.⁴ Lee, W.M.⁵ Rustgi, V.K.⁶

5
- 0032895233
- Use of high-dose interferon in the treatment of chronic hepatitis C
- (1999) Semin Liver Dis , vol.19 , pp. 25-33
- Schiffman, M.L.¹

6
- 0032475822
- Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-α therapy
- (1998) Science , vol.282 , pp. 103-107
- Neumann, A.U.¹ Lam, N.P.² Dahari, H.³ Gretch, D.R.⁴ Wiley, T.E.⁵ Layden, T.J.⁶

7
- 0025203837
- Clinical pharmacokinetics of interferons
- (1990) Clin Pharmacokinet , vol.19 , pp. 390-399
- Wills, R.J.¹

8
- 0031009603
- Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa
- (1997) Hepatology , vol.26 , pp. 226-231
- Lam, N.P.¹ Neumann, A.U.² Gretch, D.R.³ Wiley, T.E.⁴ Perelson, A.S.⁵ Layden, T.J.⁶

9
- 0033914625
- Differences in viral dynamics between genotypes 1 and 2 of hepatitis C virus
- (2000) J Infect Dis , vol.182 , pp. 28-35
- Neumann, A.U.¹ Lam, N.P.² Dahari, H.³ Davidian, M.⁴ Wiley, T.E.⁵ Mika, B.P.⁶

10
- 0031958419
- Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection
- (1998) J Virol , vol.72 , pp. 4288-4296
- Polyak, S.J.¹ McArdle, S.² Liu, S.L.³ Sullivan, D.G.⁴ Chung, M.⁵ Hofgartner, W.T.⁶

11
- 0030695103
- Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: A comparison
- (1997) Hepatology , vol.26 , pp. 1640-1645
- Tong, M.J.¹ Blatt, L.M.² McHutchison, J.G.³ Co, R.L.⁴ Conrad, A.⁵

12
- 0027178527
- Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay
- (1993) J Gen Virol , vol.74 , pp. 1093-1102
- Stuyver, L.¹ Rossau, R.² Wyseur, A.³ Duhamel, M.⁴ Vanderborght, B.⁵ Van Heuverswyn, H.⁶

13
- 0032171326
- Is there an optimal time to measure quantitative HCV RNA to predict non-response following interferon treatment for chronic HCV infection?
- (1998) J Hepatol , vol.29 , Issue.3 , pp. 362-368
- McHutchison, J.¹ Blatt, L.² Sedghi-Vaziri, A.³ Russell, J.⁴ Schmid, P.⁵ Conrad, A.⁶

14
- 0029135060
- Assessment of hepatitis C viremia using molecular amplification technologies: Correlations and clinical implications
- see comments in Ann Intern Med 1995; 123(5):383-385
- (1995) Ann Intern Med , vol.123 , Issue.5 , pp. 321-329
- Gretch, D.R.¹ Dela Rosa, C.² Carithers R.L., Jr.³ Willson, R.A.⁴ Williams, B.⁵ Corey, L.⁶

15
- 0035074416
- Hepatitis C viral kinetics in difficult to treat patients receiving high dose interferon and ribavirin
- (2001) J Hepatol , vol.34 , pp. 435-440
- Bekkering, F.C.¹ Brouwer, J.T.² Hansen, B.E.³ Schalm, S.W.⁴

16
- 0028070714
- Functional role of type I and type II interferons in antiviral defense
- (1994) Science , vol.264 , pp. 1918-1921
- Muller, U.¹ Steinhoff, U.² Reis, L.F.³ Hemmi, S.⁴ Pavlovic, J.⁵ Zinkernagel, R.M.⁶

17
- 0033914781
- Different turnover rate of hepatitis C virus clearance by different treatment regimen using interferon-beta
- (2000) J Hepatol , vol.33 , pp. 313-322
- Shiratori, Y.¹ Perelson, A.S.² Weinberger, L.³ Imazeki, F.⁴ Yokosuka, O.⁵ Nakata, R.⁶

18
- 0035552139
- Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapy
- (2001) J Viral Hepatitis , vol.8 , pp. 414-420
- McHutchison, J.G.¹ Shad, J.A.² Gordon, S.C.³ Morgan, T.R.⁴ Ling, M.-H.⁵ Garaud, J.J.⁶

19
- 0033841034
- Evaluation of long-term efficacy of interferon alpha-2b and ribavirin in combination in naive patients with chronic hepatitis C: An Italian multicenter experience
- Ribavirin-Interferon in Chronic Hepatitis Italian Group Investigators. see comments in J Hepatol 2000;33(3):482-484
- (2000) J Hepatol , vol.33 , Issue.3 , pp. 448-455
- Barbaro, G.¹ Di Lorenzo, G.² Soldini, M.³ Giancaspro, G.⁴ Pellicelli, A.⁵ Grisorio, B.⁶

20
- 0032585237
- Randomized trial of interferon alpha-2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha-2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
- (1998) Lancet , vol.352 , pp. 1426-1432
- Poynard, T.¹ Marcellin, P.² Lee, S.S.³ Niedearau, C.⁴ Minuk, G.C.⁵ Ideo, G.⁶

21
- 0001339356
- High dose induction leads to improved sustained viral clearance in HCV genotype 1 patients
- abstract 658
- (2001) Hepatology , vol.34 , Issue.4
- Larsen, A.M.¹ Rajvanshi, P.² Lee, S.³ Polyak, S.J.⁴ Gretch, D.R.⁵ Carithers, R.L.⁶

22
- 0034320232
- Hepatitis C in African Americans: Summary of a workshop
- (2000) Gastroenterology , vol.119 , pp. 1385-1396
- Howell, C.¹ Jeffers, L.² Hoofnagle, J.H.³

23
- 0034619980
- Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis
- (2000) N Engl J Med , vol.343 , pp. 1673-1680
- Heathcote, E.J.¹ Shiffman, M.L.² Cooksley, W.G.E.³ Dusheiko, G.M.⁴ Lee, S.S.⁵ Balart, L.⁶

24
- 0000268538
- Pegylated (40kDa) Interferon alfa-2a in combination with ribavirin: Efficacy and safety results from a phase III, randomized, actively controlled, multicenter study
- abstract 289
- (2001) Gastroenterology , vol.120
- Fried, M.W.¹ Shiffman, M.L.² Reddy, R.K.³ Smith, C.⁴ Marino, G.⁵ Goncales, F.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.